Estrus has been synchronized in cattle with progestogens, prostaglandins (prostaglandin F2a and its analogues), progestogen-estrogen combinations and progestogen-prostaglandin combinations. Progestogens administered for 14 to 20 d are effective in synchronizing estrus; however, fertility at the synchronized estrus is subnormal. Duration of progestogen treatment can be reduced by combining it with an estrogen. Syncro-Mate B is a progestogen-estrogen combination that results in a tightly synchronized estrous response. Prostaglandins can be used in double-or single-injection programs. Fertility of the estrus after prostaglandin treatment is similar to that of controls. Estrus also has been synchronized effectively by combining a 5-to 9 d progestogen treatment with prostaglandin at or near the end of treatment. When prostaglandin is used alone, cattle in the late stages of the luteal phase (d 11 to 15 of the estrous cycle) at the time of prostaglandin injection have a higher estrous response and may be more fertile than those injected with prostaglandin in the early part (d 6 to 9) of the luteal phase. More recently, a 14-d progestogen treatment has been combined with a prostaglandin injection given 16 to 18 d after progestogen withdrawal. This system places cattle in the late luteal phase of the estrous cycle at the time of prostaglandin injection and has resulted in an estrus with greater fertility than that immediately following progestogen treatment.
costs of labor, drugs for estrous synchronization and semen, and natural service bull costs (Pace, 1985) . Estrous synchronization also may enhance efficiency by allowing for a shortened breeding and calving season. Because the cow has a 21-d estrous cycle, cows could have three opportunities to be bred in a 45-d breeding season with synchronization of estrus at the beginning of the breeding season, whereas a 63d breeding season would be required for three breeding opportunities without synchronization of estrus. Cows that calve early during the calving season have heavier calves at weaning and longer postpartum periods for rebreeding (Dunn and Kaltenbach, 1979) . However, appropriate nutritional management of cows is critical in attaining a short calving season.
Synchronization of estrus implies the manipulation of the estrous cycle or induction of estrus to bring a large percentage of a group of females into estrus at a predetermined time. al., 1984 Females may be "inseminated according to estrus," which means that cows will be observed for signs of estrus and inseminated approximately 12 h after observed estrus. Alternatively, cows may not be observed for signs of estrus but instead may be inseminated at a fixed, predetermined time. This procedure is referred to as timed breeding, breeding by appointment or mass mating.
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Ideally, an estrous synchronization system should elicit a fertile, tightly synchronized estrous response in a high percentage of treated females. Methods of evaluating synchronization systems include estrous response (percentage of females showing estrus of those treated), synchronized conception rate (percentage of females conceiving of those inseminated), synchronized pregnancy rate (percentage of females conceiving of the total treated), and pregnancy rate at various stages of the breeding season. Distribution of estrus or b e upjohn CO., K~LUIUAJO. MI. degree of synchrony is important when evaluating a system's potential for timed breeding.
The purpose of this paper is to review methods of synchronizing estrus in the postpartum beef cow. Factors influencing success of synchronization programs also will be discussed.
Progestogens
Progestogens suppress estrus in cattle and have been used widely to alter the estrous cycle. Several progestogens have been investigated; these are summarized in Table 1 .
One of the more widely used progestogens is melengestrol acetate3 (MGA), which suppresses estrus when administered orally (Zimbelman and Smith, 1966; Roussel and Beatty, 1969; DeBois and Bierschwal, 1970; Randel et al., 1972) . Melengestrol acetate, when administered orally, is 300 to 900 times more potent than 6-methyl-17 acetoxy-progesterone (MAP), and providing .5 mg/(head.d) suppressed estrus and ovulation in nearly all animals (Zimbelman and Smith, 1966) . The level of MGA fed is related to the time of estrus following MGA withdrawal; cattle receiving lower levels of MGA showed estrus sooner than those fed higher levels of MGA (Zimbelman and Smith, 1966; Hill et al., 1971; Randel et al., 1972) . Zimbelman et al. (1970) reviewed 24 studies that addressed the effectiveness of MGA fed for 10 to 18 d as an estrous synchronization agent. The percentage of MGA-treated females in estrus in a 6-d period following treatment was similar to the percentage of controls in estrus in a 20-d period. However, the first-service conception rate was 14% lower for MGA-treated females than for controls. This reduced conception rate was temporary and was confined to breeding at estrus occurring within about 10 d after MGA withdrawal.
Fertility also is reduced after long-term administration of MAP (Hansel et al., 1961) , 6-chloro-6-dehydro-17-acetoxy progesterone (CAP; Hansel et al., 1966) and dihydroxyprogesterone acetophenide (DHPA; Wiltbank et al., 1967) .
The mechanism responsible for reduced fertility following extended progestogen treatment is not well established. Altered follicular growth and an increase in the number of atretic follicles after MGA treatment may contribute to reduced fertility (Guthrie et al., 1970; b o n d et al., 1971) . Sperm transport is reduced following insemination after progestogen treatment in the ewe (Hawk, 1971) , and fertilization rate is reduced following MGA treatment Reed and Rich, 1972; Wordinger et al., 1976) . Wishart and Young (1974) reported that cleavage rates were retarded in females exposed to progestogens. Perhaps the reduced fertility observed after progestogen treatment is due to a combination of these and other factors.
Progestogen-Estrogen Combinations
Treatment of cattle with progestogens for less than 14 d was reported not to reduce conception rate (Wiltbank and Kasson, 1968; Roche, 1974a Roche, . 1976 ). However, for these short-term progestogen systems to be effective in synchronizing estrus, a luteolytic agent must be incorporated. Estrogens are luteolytic when administered to cattle during the early part of the estrous cycle (Wiltbank et al., 1961) . Thimonier et al. (1975) treated cows with an injection of estradiol valerate followed by a norgestomet implant and reported that implanting for 13 or 15 d reduced fertility compared with implanting for 7 or 9 d. Wiltbank and GonzalezPadilla (1975) reported that a 9-d implant containing 6 mg norgestomet plus an injection of 5 mg of estradiol valerate and 3 mg of norgestomet given at the time of implant insertion successfully synchronized estrus and also induced estrus in noncycling beef heifers. This treatment now is commercially available as Syncro-Mate B4 and is approved by the Food and Drug Administration (FDA) for synchronization of estrus in dairy and beef heifers and postpartum beef cows.
Studies evaluating the effectiveness of Syncro-Mate B are summarized in Mares et al. (1977) , 5-d pregnancy rate was lower in herds in which less than 50% of the cows were cycling prior to treatment compared with herds in which greater than 50% of the cows were cycling. This likely is due to a lower first-service conception rate in herds in which cycling was poor, because Syncro-Mate B usually results in a high estrous response. Brink and Kiracofe (1988) reported a 30% conception rate in postpartum cows known to be anestrous at treatment. Similarly, Brown et al. (1988) reported a 30% conception rate in noncycling heifers treated with Syncro-Mate B vs a 48% conception rate in cycling heifers. In some studies, however, conception rate has been quite high after treatment of anestrous females with SyncroMate B (Wiltbank and Gonzalez-Padilla, 1975; Miksch et al., 1978) .
Luteal dysfunction may be one cause of reduced fertility in catlle treated with SyncroMate B Favero et al., 1988) . This may be due to insufficient LH production following implant removal (Hixon et al., 1981) .
Stage of the estrous cycle at the beginning of treatment also may influence conception rate after Syncro-Mate B. Brink and Kiracofe (1988) reported a 47% conception rate for heifers that were on d 11 or less of the estrous cycle compared with a 37% conception rate for heifers that were on d 12 or greater of the estrous cycle at the beginning of treatment. This reduced conception rate for heifers late in the estrous cycle may be due to progestogen (natural progesterone plus norgestomet) exposure. Long-term progestogen treatment has been shown to reduce conception rate.
Body condition of beef cattle influences conception rate after Syncro-Mate B treatment. Thin cattle have longer postpartum intervals to estrus (DUM and Kaltenbach, 1979) and therefore are more likely to be noncycling at the time of treatment, resulting in reduced conception rates. However, Andersen et al.
(1 987) reported that synchronized pregnancy rate was reduced in beef heifers that were greater than condition score 6, suggesting that having cattle too fat also may be demmental.
Pregnancy rates after 5 d were greater in five of six mals (Table 2) for cattle inseminated at a fixed time (usually 48 to 54 h after implant removal) following Syncro-Mate B treatment compared with cattle inseminated according to esuus. Timed insemination has the advantage of reducing labor and management for detection of estrus and cattle handling. Pregnancy rates at 25 to 28 d of the breeding season were higher for females treated with Syncro-Mate B than for control females in most mals.
Separation of calves from their dams from the time of implant removal until breeding is the label-recommended usage for Syncro-Mate B in suckled beef cows. Calf removal im-proved the estrous response (Dowling et al., 1977) and synchronized pregnancy rate in time-bred cows (Kiser et al., 1980) . However, Pace and Sullivan (1980) reported no advantage in pregnancy rate for cows treated with Syncro-Mate B with calf removal compared with no calf removal in a study utilizing 2,015 postpartum beef cows from 10 ranches. Similarly, Brown et al. (1986) showed no advantage for calf removal compared with no calf removal after Syncro-Mate B treatment. Cows in both these studies were bred according to estrus; this may explain some of the difference between these studies and that of Kiser et al. (1980) . Additionally, Kiser et al. (1980) stated that the benefit of calf removal was reduced in herds in adequate body condition.
A combination of injecting estradiol valerate and progesterone followed by a 12-d application of progesterone-releasing intravaginal devices (PRID) also is effective at synchronizing estrus in cows (Sprott et al., 1984) .
Prostaglandin F2a and Analogues
The luteolytic properties of prostaglandin Fza and its analogues are well established (Lauderdale, 1972; Louis et al., 1972; Rowson et al., 1972; Roche, 1974b; Hafs and Manns, 1975; Jackson et al., 1979; Herschler, 1983; Maffeo et al., 1983) . Because these compounds cause luteolysis, they can be used to synchronize estrus in cattle.
There are three prostaglandin products that are approved by FDA for synchronization of estrus in cattle in the U.S. These are PGFh or Lutalyd, cloprostenol or Estrumate6, and fenprostalene or Bovilene7. Label-approved dosages for each of the products are PGF2a, 25 mg; cloprostenol, 500 pg; and fenprostalene, 1 mg.
In general, PGFza and its analogues are ineffective in causing luteolysis in the early stage of the estrous cycle (Lauderdale, 1972; Rowson et al., 1972; Jackson et al., 1979; Battista et al., 1984; Kiracofe et al., 1985 glandins were developed to circumvent this problem.
One method of synchronizing estrus with prostaglandins alone is to give two injections, 10 to 12 d apart. If cattle are dismbuted equally across the day of the estrous cycle, approximately 70% of the cycling cattle should show estrus after the first injection. These cattle and the remainder of the cycling cattle should be at a stage of the estrous cycle to respond to the second injection. This system has k e n evaluated in several studies (Table 3) . Lauderdale (1979) evaluated the two-injection system in 24 herds of lactating beef cows and 22 herds of beef heifers. Pregnancy rate after 5 d was similar for cattle that were bred by estrus or time bred 80 h after the second injection and was greater for both treated groups than for controls. Synchronized concep tion rate was similar for treated cattle bred by estrus and controls. Other studies have shown that fertility following PGF2, is similar to controls (Roche, 1974k Hafs and Manns, 1975) . Interval to estrus after PGF2, is shorter for heifers than for cows (King et al., 1982) and time-breeding heifers at 80 h after the second injection may be too late, thus reducing conception rate (Burfening et al., 1978) . Burfening et al. (1978) reported that among cattle known to be cycling prior to a twoinjection system, only 71% showed estrus following the second injection. This may be due to an effect of stage of estrous cycle.
Research with beef heifers has shown that stage of the estrous cycle within the luteal phase when prostaglandin is given affects the proportion of cattle showing estrus and the time interval from prostaglandin injection to the onset of estrus (King et al., 1982) . Cattle injected during d 10 to 15 of the estrous cycle had a greater estrous response (percentage of females showing estrus following treatment) and showed estrus later than cattle injected d 5 to 9 of the estrous cycle. Similar results have been reported in lactating dauy cows (MacmilIan, 1983; Macmillan and Henderson, 1984) and stage of the estrous cycle at the time of prostaglandin injection influences interval to estrus in dairy heifers (Johnson, 1978; Refsal and Seguin, 1980; Stevenson et al., 1984) . Furthermore, conception rate may be higher following late luteal phase injections compared with early luteal phase injections (Watts and Fuquay, 1985) . However, Stevenson et al. (1984) reported no difference in conception Control A14d 'PGFza-2-E = two injections of PGFza given 10 to 12 d apart and cattle were bred according to esms following the bpcFk-2-T80 = two injections of F'GFk given 10 to 12 d apart and cattle were time bred at 80 h after the second CA14d-PGFk-l-E=cattle wereobservedforescrusandbredfor4d.thencaalenotdetectedinesuus wereinjected with dpcFk-1-E = single injection of PGF2a and cattle were bred according io estrus.
-1 = calves were removed for 48 h after the first injection of a two-injection program. 'CRlBr2 =calves were removed for 48 h after both injections of a tweinjection program. k R 2 = calves were removed for 48 h after the second injection of a two-injection program. seumd injection.
injection.
PGFza and bred according to esms. rate for heifers injected during the early luteal phase compared with the late luteal phase and bred at estrus. Cattle that show estrus after the first injection of a two-injection system usually are on d 6 to 9 of the estrous cycle at second injection. These cattle may have a reduced estrous response; this may explain partially some of the results with the two-injection system.
Attempts have been made to improve the effectiveness of the two-injection system by adding a calf removal treatment (DeSilva et al., 1984) . Removal of calves for 48 h either immediately after the first injection, the second injection, or after both injections did not improve 5-or 24-d pregnancy rate for any of the calf removal groups compared with the two-injection system without calf removal. Peters et al. (1977) increased estrous response by injecting estradiol benzoate 48 h after the second injection of PGF2a; however, conception and pregnancy rates were not improved.
Prostaglandins also have been used in single-injection programs. One of the more popular methods of using prostaglandin has been to detect estrus and artificially inseminate cattle for 4 d. inject those that have not been detected in estrus on d 5 , and continue observation for estrus and then breed from d 5 through 9. This system increases pregnancy rate of cows or heifers through 9 d of breeding compared with controls (Moody, 1979; Lauderdale et al., 1980) . This system requires more labor for detection of estrus and artificial insemination but requires less prostaglandin than the two-injection, breed by estrus program and requires less prostaglandin and semen than the two-injection, time breed program. Another single-injection system that has been used is to inject prostaglandin and breed at detected estrus for 5 d. This system increases 5-d pregnancy rate compared with controls (Lauderdale et al., 1980) . Analogues of PGF2, cause luteolysis of the mature corpus luteum in cattle. Cloprostenol has been used effectively for synchronizing estrus in cattle (Johnson, 1978; Jackson et al., 1979; Roche and Prendiville, 1979; Hardin et al.. 1980; Refsal and Seguin, 1980 Jackson et al., 1983; Seguin et al., 1983) as has fenprostalene (Herschler, 1983) and alfaprostol (Jochle et al., 1982; Schilling et id., 1982; Maffeo et al., 1983; Kiracofe et al., 1985; Hansen et al., 1987) . Little information is available in the scientific literature on direct comparisons among the prostaglandins.
Progestogen-Prostaglandin Combinations
Instead of administering an estrogen at the beginning of a progestogen treatment to reduce the length of progestogen exposure, a prostaglandin may be administered at or near the end of a progestogen treatment (Table 4) . This approach was first taken by Heersche et al. (1974) and Wishart (1974) . They combined a norgestomet implant with an injection of PGF2a before or at implant removal. At the end of the implant period, cattle should either have a corpus luteum that is susceptible to regression by prostaglandin or have undergone natural corpus luteum regression already. Therefore, cattle should show estrus soon after implant removal and prostaglandin injection.
When beef heifers were treated with a 7-d norgestomet implant and injected with PGF2a on d 6 or 7 after implantation, 93% showed estrus within 5 d and 62% of these conceived, which was similar to a 60% fxstservice conception rate for controls (Heersche et al., 1979) . Combined with an injection of alfaprostol at implant removal, a 9-d norgestomet implant was as effective as Syncro-Mate B in postpartum beef cows Brown et al., 1986) . Whittier et aI. (1986) reported that a 7-d norgestomet implant with alfaprostol on d 7 resulted in conception and pregnancy rates similar to those obtained with Syncro-Mate B; however, the degree of synchrony was better for heifers treated with Syncro-Mate B.
A tighter synchrony of estrus, which is important for timed insemination, can be attained by injecting prostaglandin 2 d prior to norgestomet implant removal (Odde et al., 1984) . However, this requires an additional day of cattle handling. This concept also has been used by Bed (1983) and Smith et al. (1984) , who applied a PRID for 7 d and injected PGF2a on d 6. In both studies, synchronized pregnancy rate was greater for the PRID-PGFza group than for cattle treated with two injections of PGF2a 11 d apart.
A short-term feeding of MGA was combined with an injection of PGF2, at the end of MGA feeding (Beal and Good, 1986) . This system induced cycling successfully in some noncycling cows. However, fertility of the estrus after treatment in cattle known to be cycling prior to this treatment was reduced relative to controls (Bed et al., 1988) . This reduced fertility was present in cattle that were greater than d 13 of the estrous cycle at the progestogen treatment may lower fertility, beginning of treatment. This day of cycle even though the progestogen treatment is 9 d effect was similar to that reported for Syncro-or less.
Mate B (Brink and Kiracofe, 1988) and again
To overcome the potential problem of suggests that breeding immediately following reduced fertility when breeding following a progestogen treatment (Miksch et al., 1978; Bed et al., 1988) and to take advantage of the fact that PGF2a is more effective during the late luteal phase (d 10 to 15) than during the early luteal phase (King et al., 1982; Tanabe and Hann, 1984; Watts and Fuquay, 1985) , Brown et al. (1988) developed a system in which MGA was fed for 14 d and PGF2, was administered 16 to 18 d after the last day of MGA feeding. This system was designed to place cattle in the late luteal phase of the estrous cycle at the time of PGF2a administration. This system was compared to SyncroMate B (Brown et al., 1988) and to a 7-d MGA treatment with PGF2, given on d 7 in beef heifers (Mauck et al., 1988) . The 14-d MGA treatment with PGF2a given on d 17 after the last day of MGA feeding resulted in greater synchronized conception and pregnancy rates. Although degree of synchrony (percentage in esms in peak 24-h period) was similar between this system and Syncro-Mate B, these systems have not been compared in cattle that were inseminated at a predetermined, fixed time.
Applying this concept to postpartum cows, administered a norgestomet implant for 14 d and injected alfaprostol 16 d after implant removal. This system was compared to Syncro-Mate B. Although esmous response was greater for cows treated with Syncro-Mate B, synchronized conception rate was greater for the norgestomet-alfaprostol group, with synchronized pregnancy rate through 5 d of breeding being similar for the two groups. Yelich et al. (1988) evaluated the 14-d MGA treatment with PGF2, given 17 d after the last MGA feeding in postpartum cows. They reported that synchronized pregnancy rate was high (61%) for cows with a condition score of 5 or greater (Richards et al., 1986) compared with 19% for cows with a condition score of 4 or less, suggesting that this system was effective in postpartum cows for which body condition was at least moderate.
Management Factors Affecting Estrous Synchronization
Criteria used by cattle producers to evaluate estrous synchronization programs are not limited to reproductive results. Cost and ease of application also are important. Reproductive results will depend on the synchronization program, the cattle (cyclicity level and fertility, nutritional status, genotype, docility), semen fertility, AI technician capability, and estrous detection ability (if not breeding at a predetermined fixed time). Cost depends on which product and which synchronization program is used. Ease of application depends on the synchronization program, cattle handling facilities and docility of the cattle. The relative importance of each factor varies greatly for different producers. For example, in some situations, estrous synchronization with artificial insemination is impossible unless timed insemination can be used. Conversely, for some producers, detection of estrus can be accomplished with little difficulty and a tightly synchronized estrus allowing for timed insemination is not critical.
A frequent concern expressed by producers is that estrous-synchronized cows may all calve at once and calf losses may be high if weather conditions are poor. However, cows that conceive to a synchronized estrus have normal variation in gestation length, and less than 20% would be expected to calve on the peak day in the calving season (Odde et al., 1987) .
Beef heifers frequently are maintained in a more confined environment than cows are and therefore may be more likely candidates for synchronization of estrus and artificial insemination. In cows or heifers, the factor most limiting the success of the synchronization program is percentage cycling. Percentage cycling at the beginning of the breeding season in heifers is influenced largely by age and nutrition, whereas in beef cows it is influenced by calving date, nutrition and suckling. With appropriate nutritional management, several synchronization programs can be used successfully in both cows and heifers.
Implications
Developments in estrous synchronization of cattle over the last 40 yr are reviewed in this paper. The development and subsequent commercial availability in the U.S. of prostaglandin PGF2, and its analogues (Lutalyse; Estrumate; Bovilene) and Syncro-Mate B have facilitated use of artificial insemination in many cattle operations. These products also have been helpful in increasing pregnancy rate at fixed times of the breeding season. Recent developments in progestogen-prostaglandin combinations may result in additional useful estrous synchronization programs for producers.
